# Avalyn Pharma Inc.: Form SCHEDULE 13D, filed May 8, 2026

- Company: [Avalyn Pharma Inc.](/companies/avln.md) (CIK 1540171)
- Form: SCHEDULE 13D
- Filed: 2026-05-08
- Accepted by EDGAR: May 8, 2026, 18:52 ET
- Period: not reported
- Accession: 0000899140-26-000428
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1540171/000089914026000428/xslSCHEDULE_13D_X02/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1540171/000089914026000428/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1540171/000089914026000428/xslSCHEDULE_13D_X02/primary_doc.xml

Filed May 8, 2026.
Source: SEC EDGAR, the filing index for accession 0000899140-26-000428. Last ingested by Listed: Oct 24, 2026, 15:13 ET. No prices; not investment advice.